Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie and Janssen announce failure of cancer drug Imbruvica in Phase 3 trial

pharmafileJuly 17, 2018

Tag: AbbVie , Janssen , cancer drug

PharmaSources Customer Service